Listed

Gentherm Inc: Form 10-Q for the period ended Mar 31, 2018

Filed with the SEC on Apr 27, 2018 and accepted by EDGAR at Apr 27, 2018, 16:30 ET.

Share

Management's discussion and analysis

As filed, 24,575 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Forward-Looking Statements

This Report contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent our goals, beliefs, plans and expectations about our prospects for the future and other future events, such as our ability to finance sufficient working capital, the amount of availability under our credit agreement and other indebtedness, our ability to continue to maintain or increase sales and profits of our operations, and the sufficiency of our cash balances and cash generated from operating, investing and financing activities for our future liquidity and capital resource needs. Reference is made in particular to forward-looking statements included in this “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Such statements may be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “believe”, “estimate”, “anticipate”, “intend”, “continue”, or similar terms, variations of such terms or the negative of such terms. The forward-looking statements included in this Report are made as of the date hereof or as of the date specified and are based on management’s current expectations and beliefs. Such statements are subject to a number of assumptions, risks, uncertainties and other factors, which are set forth in “Item 1A. Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2017, and subsequent reports filed with or furnished to the Securities and Exchange Commission, and which could cause actual results to differ materially from that described in the forward-looking statements. Except as required by law, we expressly disclaim any obligation or undertaking to update any forward-looking statements to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

The following discussion and analysis should be read in conjunction with, and is qualified in its entirety by, our consolidated financial statements and related notes thereto included elsewhere in this Report and in our Annual Report on Form 10-K for the year ended December 31, 2017.

Overview

Gentherm Incorporated is a global technology and industry leader in the design, development, and manufacturing of innovative thermal management technologies. Our products provide solutions for automotive passenger comfort and convenience, battery thermal management, remote power generation, patient temperature management, environmental product testing and other consumer and industrial temperature control needs. Our automotive products can be found on the vehicles of nearly all major automotive manufacturers operating in North America, Europe and Asia. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilities and to identify future thermal technology product opportunities in both automotive and other markets. We concentrate our research on the development of new technologies and new applications from existing technologies to create product and market opportunities for a wide array of thermal management solutions.

Our automotive products are sold to automobile and light truck OEMs or their tier one suppliers. Inherent to the automotive supplier market are costs and commitments that are incurred well in advance of the receipt of orders and resulting revenues from customers. This is due in part to automotive manufacturers requiring the design, coordination and testing of proposed new components and sub-systems. Revenues from these expenditures are typically not realized for two to three years due to this development cycle.

The Company has two reportable segments for financial reporting purposes: Automotive and Industrial. See Note 5 to our consolidated condensed financial statements for a description of our reportable segments as well as their proportional contribution to the Company’s reported product revenues and operating income. The financial information used by our chief operating decision maker to assess operating performance and allocate resources is based on these reportable segments.

Etratech

On November 1, 2017, we acquired substantially all of the assets and assumed substantially all of the operating liabilities of Etratech Inc. (“Etratech”), an Ontario corporation and all of the outstanding shares of Etratech Hong Kong, an entity organized under the laws of Hong Kong, in an all-cash transaction. Etratech manufactures advanced electronic controls and control systems for the automotive, RV and marine, security, medical and other industries. Etratech’s world headquarters and North American manufacturing operations are located in Burlington, Canada. See Note 3 to the consolidated condensed financial statements for additional information regarding the acquisition of Etratech.

North American Reorganization

On January 4, 2016 and January 5, 2016, the Company completed reorganization transactions (the “Reorganization”) related to our North American business operated from Windsor, Ontario, Canada (the “Windsor Operations”). As part of our original integration plan to eliminate redundancies associated with the 2011 acquisition of Gentherm GmbH (formerly named W.E.T. Automotive Systems AG), the Windsor Operations have been consolidated into our existing European and North American facilities. As a result of the Reorganization, some of the business activities previously performed by the Windsor Operations are now being performed by other subsidiaries.

Related to the Reorganization, the Company declared intercompany dividends, incurred and paid withholding taxes to the Canadian Revenue Agency of $7.6 million during 2016. Additionally, the Company incurred income tax expense of $2.5 million related to the intercompany dividends. These amounts incurred are expected to cover all future intercompany dividends needed to distribute the remaining earnings of the subsidiary to its parent in conjunction with the potential future liquidation of the subsidiary.

In addition to the $7.6 million of withholding tax and $2.5 million of income taxes, the Reorganization required the Company to make a one-time income tax payment of approximately $32.6 million. The one-time income tax payment was accrued during the first quarter of 2016; however, the Company also recorded an offsetting deferred charge for approximately the same amount because the one-time income tax payment will result in tax deductions against income taxes in future periods. Therefore, the income tax payment did not have a material impact on the Company’s earnings during the first quarter of 2016 nor any subsequent quarter. The withholding tax payment was paid entirely in 2016. The income tax payments of $2.5 million and $32.6 million were paid during the first quarter of 2017.

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations are based upon our consolidated condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. See Note 2 to our consolidated condensed financial statements for information about critical accounting policies, accounting standard updates adopted during the three-month period ended March 31, 2018 and their impact on the Company’s consolidated financial statements, and recently issued accounting policies not yet adopted.

Results of Operations First Quarter 2018 Compared with First Quarter 2017

Product Revenues. Product revenues for the three-month period ended March 31, 2018 (“First Quarter 2018”) were $261.9 million compared with product revenues of $249.3 million for the three-month period ended March 31, 2017 (“First Quarter 2017”), an increase of $12.6 million, or 5%. Higher product revenues in the automotive segment which increased by $18.2 million, or 8.2%, to $240.0 million were partially offset by lower industrial segment product revenues which decreased by $5.6 million, or 20%, to $21.9 million. The higher automotive segment sales included $15.2 million related to the acquisition of Etratech and a favorable effect from currency translation of $10.5 million. Etratech was acquired on November 1, 2017 and therefore no product revenue was reported for Etratech during First Quarter 2017. On a pro-forma basis, Etratech revenue increased by 20%.

Without the benefit of the currency translation and the Etratech acquisition, automotive segment product revenue would have decreased by 2.2%. This decrease occurred as a result of slowing automotive production volumes especially in our most important geographic markets and at two of our largest customers, annual price reductions totaling $5.0 million and from lower average selling price of climate controlled seats (“CCS”) resulting from certain vehicle programs changing technologies from the higher priced active cooling application to heated and ventilated seating technology. In North America, which represented approximately 47% of our automotive revenue during First Quarter 2018, automotive production decreased by 2.6% during First Quarter 2018. Lower production significantly impacted two important customers. Automotive production at General Motors, representing 15% of our product revenues, was down more than 8% in North America and production for Hyundai, representing 8% of our product revenues, was down by 3.75% in Korea and down 5.7% in North America. These lower production volumes impacted our CCS products disproportionately. Most of our other automotive products had higher revenue despite the weak production volumes on a currency adjusted basis. Automotive cable systems were particularly strong growing by $5.1 million, or 24%, to $26.9 million. Steering wheel heaters grew by $2.5 million, or 17%, to $17.6 million. Seat heaters also increased by $6.6 million, or 8.5% to $84.2 million.

Product revenues from Gentherm Global Power Technologies (“GPT”), included in the industrial segment, totaled $4.6 million which represented a decrease of $2.9 million, or 39%. This decrease was mainly due to significantly lower custom project revenue. Custom projects, which typically represent more than 50% of GPT’s product revenue, tend to vary significantly period-to-period due to timing of the relatively large per unit revenue. Revenue for Cincinnati Sub-Zero Products, LLC (“CSZ”) during First Quarter 2018 was $17.3 million, representing a decrease of $2.7 million, or 14%. This decrease was mainly due to $2.7 million in lower sales of the blood heater-cooler product that was higher during First Quarter 2017 due to the regulatory disruptions impacting a competitive product.

Cost of Sales. Cost of sales increased to $183.3 million during First Quarter 2018 from $164.1 million during First Quarter 2017. This increase of $19.2 million, or 12%, was due to the higher product revenue and a lower gross margin percentage. The gross margin percentage during First Quarter 2018 decreased to 30.0% from 34.2% during First Quarter 2017 mainly as a result of annual price reductions, increased manufacturing expenses, changes in product mix favoring lower margin products and higher expenses from currency translation. Annual price reductions start in the first quarter and are expected to be offset by lower supplier and other costs as those programs begin to take effect throughout the year. Increased expenses included labor expense inflation at our Ukraine factory, and factory launch expenses for the new advanced battery thermal management product in our Macedonia facility. An unfavorable shift in product mix largely was due to lower sales for higher margin products including CCS, GPT and the medical products of CSZ.

Net Research and Development Expenses. Net research and development expenses were $23.3 million during First Quarter 2018 compared to $19.5 million in First Quarter 2017, an increase of $3.8 million, or 19%. This increase was primarily driven by higher costs for additional resources, including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products. The increase also included approximately $1.0 million in foreign currency translation and the net research and development expenses of Etratech totaling $423 thousand. New product development includes automotive cooled storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices, battery management systems, advanced automotive electronics solutions and other potential products.

Research and development reimbursement totaled $2.4 million during First Quarter 2018 and $2.2 million during First Quarter 2017. This increase was mainly due the addition of Etratech.

Selling, General and Administrative Expenses. Selling, general and administrative expenses increased to $34.6 million during First Quarter 2018, an increase of $3.8 million, or 12%, from $30.8 million during First Quarter 2017. This increase includes approximately $1.1 million in higher expenses related to currency translation and $1.8 million in selling, general and administrative expenses of Etratech.

Foreign currency gain (loss). During First Quarter 2018 we incurred a net foreign currency loss of $4.6 million which included a net realized loss of $936 thousand and a net unrealized loss of $3.6 million. The unrealized loss is primarily the result of holding significant amounts of U.S. Dollar (“USD”) cash at our subsidiaries in Europe which have the European Euro (“EUR”) as the functional currency and due to certain intercompany relationships between these European subsidiaries and our U.S. based companies. During First Quarter 2018, the USD weakened relative to the EUR. If the USD continues to weaken we will likely have further unrealized currency losses whereas if the USD strengthens we will likely have unrealized gains. First Quarter 2017, we had a foreign currency loss of $1.3 million. In comparison to 2017, the foreign currency impact in 2018 was higher due to a smaller change in currency exchange rates during First Quarter 2018 as compared to First Quarter 2017.

Income Tax Expense. We recorded an income tax expense of $3.0 million during First Quarter 2018 representing an effective tax rate of 19% on earnings before income tax of $16.0 million. During First Quarter 2017, we recorded an income tax expense of $7.2 million on earnings before tax of $32.6 million, or 22%. The effective tax rate for First Quarter 2018 differed from the Federal statutory rate of 21% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions offset by the international provisions from the U.S. tax reform, such as global intangible low-tax income (“GILTI”), enacted in December 2017. The effective tax rate for First Quarter 2017 was lower than the U.S. Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions.

Industrial Segment Operating Loss. The Industrial segment, which includes CSZ, GPT and our advanced research and development activities, reported an operating loss totaling $6.8 million and $2.5 million during First Quarter 2018 and First Quarter 2017, respectively, an increase of $4.3 million, or 172%. We incurred these losses for three reasons. First, the advanced research and development activities, the total cost for which were $4.0 million and $3.9 million, during First Quarter 2018 and First Quarter 2017, respectively, are focused on products and technologies that are currently not generating product revenues. We expect that many of the individual projects include in the business unit will generate profitable revenue in future periods. Next, CSZ’s $1.2 million of expenses associated with new direct sales force is not yet offset by a corresponding increase in the amount of revenue and related operating income. We continue to believe that the direct sales force will lead to higher CSZ product revenue in future periods that will generate operating profits in excess of the costs for the direct sales team. Finally, the operating loss was higher during First Quarter 2018 as compared to First Quarter 2017 due mainly to the lower product revenues which could not be offset by a corresponding reduction in fixed costs.

Liquidity and Capital Resources

Cash and Cash Flows

The Company has funded its financial needs primarily through cash flows from operating activities and equity and debt financings. Based on its current operating plan, management believes cash and cash equivalents at March 31, 2018, together with cash flows from operating activities, and borrowing available under our credit agreement, are sufficient to meet operating and capital expenditure needs, and to service debt, for at least the next 12 months. However, if cash flows from operations decline, we may need to obtain alternative sources of capital and reduce or delay capital expenditures, acquisitions and investments, all of which could impede the implementation of our business strategy and adversely affect our results of operations and financial condition. In addition, it is likely that we will need to complete one or more equity or debt financings if we consummate any significant acquisition or a number of smaller acquisitions. There can be no assurance that such capital will be available at all or on reasonable terms, which could adversely affect our future operations and business strategy.

The following table represents our cash and cash equivalents and short-term investments:

(In thousands)

Three Months Ended March 31, 2018 Year Ended December 31, 2017
Cash and cash equivalents at beginning of period $103,172 $177,187
Cash from operating activities 5,590 49,880
Cash used in investing activities (8,393) (117,688)
Cash used in financing activities (35,400) (31,564)
Foreign currency effect on cash and cash equivalents 5,513 25,357
Cash and cash equivalents at end of period $70,482 $103,172

Cash Flows From Operating Activities

We manage our cash, cash equivalents and short-term investments in order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. The following table compares the cash flows from operating activities during First Quarter 2018 and First Quarter 2017:

(In thousands)

Operating Activities: Three Months Ended March 31, 2018 2017 Change
Net income $12,966 $25,402 $(12,436)
Non-cash adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization 12,892 10,192 2,700
Deferred income taxes (707) 676 (1,383)
Stock compensation 2,202 2,303 (101)
Defined benefit plan expense 298 (16) 314
Provision for doubtful accounts 41 (54) 95
Loss on sale of property and equipment 85 103 (18)
Net income before changes in operating assets and liabilities 27,777 38,606 (10,829)
Changes in operating assets and liabilities:
Accounts receivable (9,691) (13,900) 4,209
Inventory 1,903 (2,407) 4,310
Prepaid expenses and other assets (4,881) (6,492) 1,611
Accounts payable 1,290 1,094 196
Accrued liabilities (10,808) (38,237) 27,429
Net cash provided by (used in) operating activities 5,590 (21,336) 26,926

Cash provided by operating activities during First Quarter 2018 was $5.6 million, representing an increase of $26.9 million from cash used in operating activities during First Quarter 2017, which was $21.3 million. The following table highlights significant differences between the operating cash flows for the periods ending March 31, 2018 and 2017, respectively:

27

(In thousands)

Net cash used in operating activities during First Quarter 2017 $(21,336)
Decrease from lower net income before changes in operating assets and liabilities (10,829)
Taxes paid related to the Reorganization 35,100
Other changes in working capital, net. 2,655
Net cash provided by operating activities during First Quarter 2018 $5,590

Net income before changes in operating assets and liabilities decreased due to lower gross margin, higher net research and development expense and higher selling, general and administrative expenses during First Quarter 2018 as compared to First Quarter 2017. These unfavorable effects to operating cash flows were offset by income tax payments related to the Reorganization during First Quarter 2017. Other changes in working capital, net primarily consist of favorable cash flows related to accounts receivable, prepaid expenses and other assets and unfavorable amounts related to inventory and accounts payable.

Working Capital

The following table illustrates changes in working capital during First Quarter 2018:

(In thousands)

Working capital at December 31, 2017 $289,754
U.S. Revolving Note repayment (35,000)
Foreign currency effect on working capital 1,719
Account receivable 9,691
Adoption of ASU 2016-16 22,585
Adoption of ASU 2014-09 (4,105)
Other Items (3,374)
Working capital at March 31, 2018 $281,270

Our working capital decreased due to the repayment of a portion of the U.S. Revolving Note outstanding balance, offset by three significant increases, including currency translation, an increase in accounts receivable and non-cash adjustments from the adoption of new accounting standard updates. In March 2018, management repaid $35.0 million of the outstanding U.S. Revolving Note balance from cash repatriated from foreign subsidiaries. The currency impact of $1.7 million on working capital is mainly the result of the currency translation of working capital at our European subsidiaries. At March 31, 2018 the U.S. Dollar/European Euro exchange rate was $1.20 as compared with an exchange rate of $1.23 at December 31, 2017. Approximately 20% of our product revenues are generated in Europe. Working capital was also impacted by an increase in account receivable, which was driven by higher sales in March 2018 as compared to December 2017. Our sales are typically lower in December each year due to temporary factory holiday shut-downs at our automotive customers. Lastly, working capital was impacted by the adoption of Accounting Standard Update 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory” and Accounting Standard Update 2014-09, “Revenue from Contracts with Customers (Topic 606).” See Note 2 to our consolidated condensed financial statements for information about these accounting standard updates and their impact on the Company’s consolidated financial statements.

Cash Flows From Investing Activities

Cash used in investing activities was $8.4 million during First Quarter 2018, reflecting purchases of property and equipment related to expansion of production capacity, including at our newest facilities in Mexico, Vietnam and Macedonia, and replacement of existing equipment.

Cash Flows From Financing Activities

Cash used in financing activities was $35.4 million during First Quarter 2018, reflecting payments of principal on the U.S. Revolving Note and the DEG China Loan (each as defined below) totaling $35.5 million in aggregate. As of March 31, 2018, the total availability under the Revolving Note was $255.9 million. Cash was also paid for cancellations of restricted stock awards totaling $659 thousand.

Off-Balance Sheet Arrangements

We use letters of credit to guarantee our performance under specific construction contracts executed by our subsidiaries, GPT and CSZ. The expiration dates of the letter of credit contracts coincide with the expected completion date of the contract. Extensions are normally made if performance obligations continue beyond the expected completion date. At March 31, 2018, we had outstanding letters of credit of $54 thousand, a decrease from $141 thousand at December 31, 2017.

Market risk

As filed, 6,157 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our exposure to market risk for changes in interest rates relates primarily to our debt obligations and foreign currency contracts. We have in the past, and may in the future, place our investments in bank certificates of deposits, debt instruments of the U.S. government, and in high-quality corporate issuers.

We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.

The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge our exposure to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of $32.2 million and $29.3 million outstanding at March 31, 2018 and December 31, 2017, respectively.

The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years. We had copper commodity swap contracts with a notional value of $0 and $404 thousand outstanding at March 31, 2018 and December 31, 2017, respectively.

We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive income (loss) in the consolidated condensed balance sheet. When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive income (loss) is recorded in earnings in the consolidated condensed statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. We record the ineffective portion of foreign currency hedging instruments, if any, to foreign currency gain (loss) in the consolidated condensed statements of income. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.

The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term. Information related to the fair values of all derivative instruments in our consolidated condensed balance sheet as of March 31, 2018 is set forth in Note 7 to the consolidated condensed financial statements included herein.

Interest Rate Sensitivity

The table presents principal cash flows and related weighted average interest rates by expected maturity dates for each of the Company’s debt obligations. The information is presented in U.S. dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in US dollars ($USD) or European Euros (€EUR), as indicated in parentheses.

March 31, 2018

(In thousands except rate information)

Liabilities Long Term Debt: Expected Maturity Date 2018 2019 2020 2021 2022 Thereafter Total Fair Value
Fixed Rate (€EUR) $492 $985 — — — — $1,477 $1,500
Fixed Interest Rate 4.25% 4.25% 4.25%
Variable Rate ($USD) — — — — $94,000 — $94,000 $94,000
Average Interest Rate 3.38% 3.38%
Fixed Rate ($USD) $2,500 $2,500 $2,500 $2,500 $2,500 $1,250 $13,750 $13,700
Fixed Interest Rate 5.21% 5.21% 5.21% 5.21% 5.21% 5.21% 5.21%

30

Exchange Rate Sensitivity

The table below provides information about the Company’s foreign currency forward exchange rate agreements that are sensitive to changes in foreign currency exchange rates. The table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates for each type of foreign currency forward exchange agreement. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.

March 31, 2018

(In thousands except rate information)

Anticipated Transactions And Related Derivatives $US functional currency Forward Exchange Agreements: (Receive MXN/Pay USD$) Expected Maturity or Transaction Date 2018 2019 2020 2021 2022 Thereafter Total Fair Value
Total Contract Amount $25,503 $4,075 — — — — $29,578 $1,158
Average Contract Rate 19.41 19.63 19.44
(Receive HUF/Pay EUR)
Total Contract Amount $1,763 — — — — — $1,763 $10
Average Contract Rate 314.08 314.08
(Receive CAD/Pay USD$)
Total Contract Amount $856 — — — — — $856 $(1)
Average Contract Rate 1.29 1.29

Controls and procedures

As filed, 1,802 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a) Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this quarterly report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2018, our disclosure controls and procedures were effective to ensure the information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods prescribed by the Securities and Exchange Commission, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

(b) Changes in Internal Control over Financial Reporting

Beginning January 1, 2018, we implemented ASC 606, Revenue from Contracts with Customers. Although the new revenue recognition standard is expected to have an immaterial impact on our ongoing net income (loss), we did implement significant changes to our processes related to revenue recognition and the control activities within them. These included the development of new policies based on the five-step model provided in the new revenue recognition standard, new training, contract review requirements, and gathering of information provided for disclosures. See note 2 to our consolidated condensed financial statements for additional information regarding the adoption of the new accounting standard.

Risk factors

As filed, 254 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There were no material changes in our risk factors previously disclosed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2017. You should carefully consider the risks and uncertainties described therein.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Gross profit3 months2018-01-01 to 2018-03-31$78.6mus-gaap:GrossProfit
Research and development3 months2018-01-01 to 2018-03-31$23.3mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2018-01-01 to 2018-03-31$34.6mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2018-01-01 to 2018-03-31$20.7mus-gaap:OperatingIncomeLoss
Income tax3 months2018-01-01 to 2018-03-31$3.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2018-01-01 to 2018-03-31$13.0mus-gaap:ProfitLoss
Diluted EPS3 months2018-01-01 to 2018-03-31$0.35us-gaap:EarningsPerShareDiluted
Basic EPS3 months2018-01-01 to 2018-03-31$0.35us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2018-01-01 to 2018-03-3136,873,407 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Capital expenditure3 months2018-01-01 to 2018-03-31$8.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2018-03-31$70.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-03-31$445.8mus-gaap:AssetsCurrent
Total assetsAt period end2018-03-31$901.4mus-gaap:Assets
Current liabilitiesAt period end2018-03-31$164.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-03-31$291.0mus-gaap:Liabilities
Long-term debtAt period end2018-03-31$105.7mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2018-03-31$3.5mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2018-03-31$610.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-18-009594. Last ingested by Listed: Oct 26, 2026, 17:44 ET. Listed shows no prices and gives no investment advice.